CRT Board of Directors

The Cancer Research Trust’s Board of Directors are committed to the highest standards of corporate governance and ethics. The Board is comprised of the following four members:

Peter Mansell (Chairman) BComm, LLB, FAICD

Peter Mansell
Mr Peter Mansell practised as a corporate and resources lawyer for over 35 years before he retired from practice in 2006. In Australia he was a corporate and resources partner of legal firm Freehills, the predecessor firm to Herbert Smith Freehills, and at various times was the Managing Partner of the Perth office, a member of the firm’s National Board and the Chair of the firm’s National Board.

He has extensive experience as a non-executive director and as a Board Chair. In addition to his current directorships, Peter has previously held positions on West Australian Newspapers Holdings Ltd (Chair), Zinifex Ltd (Chair), Foodland Associates Ltd and OZ Minerals Ltd. He also served as the Chair of Western Power.

Peter’s current listed company directorships are Energy Resources of Australia Ltd (Chair) and Tap Oil Ltd.

His current unlisted directorships are Aurecon Group (Pty) Ltd and Foodbank of Western Australia Inc (Chair) and Foodbank of Australia Limited.

 

Professor Peter Klinken BSc (Hons), PhD, DipEd

Peter Klinken
Professor Klinken is a leading Western Australian medical research scientist, highly regarded for his work in advancing the understanding of genes involved in leukaemia, cancer and anaemia. His many research achievements include the discovery of a gene that suppresses the growth of tumours.

After obtaining his PhD from The University of Western Australia, he undertook research at the US National Institutes of Health in Washington and the Walter and Eliza Hall Institute in Melbourne.

His previous roles have included Professor in Clinical Biochemistry at The University of Western Australia; Director of Research at the Royal Perth Hospital; and the Director of the Harry Perkins Institute of Medical Research (previously the Western Australian Institute for Medical Research).

Under his stewardship, the Perkins Institute attracted world-class national and international researchers to the State and made numerous acclaimed medical discoveries. He also spear-headed the development of two new state-of-the-art medical research facilities, Perkins North in Nedlands (QEII Medical Centre) and Perkins South in Murdoch (Fiona Stanley Hospital).

Professor Klinken was appointed as Chief Scientist of Western Australia in June 2014 and is Western Australia’s third Chief Scientist, since the role was established in 2003.

Professor Klinken brings a wealth of knowledge and expertise to the role of Chief Scientist. His input will support the Government in growing the State’s science industries to achieve future prosperity for Western Australians.

 

Peter Leonhardt FCA, FAICD (Life)

Peter Leonhardt
Mr Peter Leonhardt has been a non-executive director and business adviser for over 15 years.

His prior experience encompassed thirty-five years in professional practice as a Chartered Accountant with PricewaterhouseCoopers, including over twenty years as a partner of the firm and positions in four offices in Australia and overseas.

Peter held appointments as Managing Partner of Coopers & Lybrand in Western Australia and as a member of the firm’s National Board for six years, roles that carried responsibility for the strategic direction and management of the firm.

From 1991 to 1999 he was a Member of the State Council of the AICD and is a Life Fellow.

Currently he is Chairman of Carnarvon Petroleum Limited and a director of CTI Logistics Limited.

Peter is also a long-standing member of the Western Australian Yachting Foundation. He was formerly a founding director of the Perkins Institute of Medical Research, which he served for 17 years, Chairman of St Hilda’s Anglican School for Girls, a member of the advisory board of the Perth International Arts Festival and a director of the organising company for the 2011 Perth ISAF World Sailing Championships held in Fremantle.

Professor Ruth Ganss BSc, PhD

Ruth Ganss
Professor Ruth Ganss is the inaugural Woodside Translational Cancer Research Fellow, Head of the Vascular Biology and Stromal Targeting Laboratory and Scientific Head of the Cancer Division at the Harry Perkins Institute of Medical Research in Perth, Western Australia. She obtained her PhD at the University of Heidelberg, Germany in 1994. During the last decades, her research at the University of California, San Francisco, the German Cancer Research Center in Heidelberg, and since 2006 at the Harry Perkins Institute has focused on vascular aspects of tumour immunity. Her current research activities focus on translational anti-cancer aspects of stromal remodelling and immunotherapy.

Dr Joost Lesterhuis MD, PhD

Joost Lesterhuis
Dr (Willem) Joost Lesterhuis is an NHMRC RD Wright Research Fellow at the University of Western Australia and an Honorary Research Fellow at Telethon Kids Institute. He has a background as a dual-trained medical oncologist and basic researcher in tumour immunology and cancer biology.

His research focuses on identifying new effective treatment combinations in sarcoma and mesothelioma, focusing on immunotherapy.

Joost obtained his MD at the Free University in Amsterdam 2001, and completed his medical oncology specialisation and his PhD in cancer immunology at the Radboud University in Nijmegen, The Netherlands in 2010. From 2011-2012 he was a visiting post-doc at the University of Western Australia. Since 2013, when he and his family moved permanently to Australia, he has been a fulltime research fellow at the School of Biomedical Sciences at UWA, with special focus on cancer immunology research. Since October 2018 he heads the Sarcoma Group at the Cancer Centre of the Telethon Kids Institute.

Joost published over 50 peer-reviewed publications, and translated several of his laboratory findings into clinical trials. He was awarded an NHMRC Excellence Award in 2017.